Frontage Laboratories is expanding its bioanalytical laboratories in the US, in Exton, P.A.
The expansion will include an additional 10,000 square feet of laboratory space to support biologic drug development, cell and gene therapy development as well as biomarker analysis.
Additionally, the expansion will establish a center of excellence for cell and gene therapies that will include dedicated labs in DNA separation, purification, flow cytometry, and cell culture.
The expansion will also provide greater biomarker, pharmacokinetic, and immunogenicity bioanalytical capability to support large phase II-IV studies.
Moreover, the support services are also being enhanced, including sample management and sample storage space, as part of the expansion.
The instrument capacity for liquid chromatography with tandem mass spectrometry and inductively coupled plasma mass spectrometry is also being expanded to support both large and small molecule as well as elemental analysis.
The expansion is scheduled for completion in the fourth quarter of 2019.
Specifications:
| Name | Frontage Laboratories |
| Location | USA |
| Type | Expansion |
| Schedule | Scheduled to be operational by Q4-2019 |
